Detalhe da pesquisa
1.
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Cancer Immunol Immunother
; 72(1): 91-99, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729418
2.
Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit.
Support Care Cancer
; 27(5): 1679-1686, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30120556
3.
Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France.
Oncology
; 95(6): 337-343, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30278447
4.
Health-related quality of life in elderly patients with advanced non-small cell lung cancer comparing carboplatin and weekly paclitaxel doublet chemotherapy with monotherapy.
Eur Respir J
; 48(3): 861-72, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27338193
5.
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
Eur Respir J
; 46(5): 1440-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26381515
6.
Second-line therapy in elderly patients with advanced nonsmall cell lung cancer.
Eur Respir J
; 43(1): 240-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114964
7.
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).
Lung Cancer
; 193: 107843, 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38830303
8.
Bronchial colonisation in patients with lung cancer: a prospective study.
Eur Respir J
; 42(1): 220-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100491
9.
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer.
J Cancer Res Clin Oncol
; 149(16): 15095-15102, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626173
10.
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Target Oncol
; 18(6): 905-914, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966566
11.
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
J Immunother
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807621
12.
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018.
Eur J Cancer
; 183: 38-48, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36801605
13.
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer.
J Thorac Oncol
; 18(10): 1408-1415, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217096
14.
Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.
Lancet
; 378(9796): 1079-88, 2011 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21831418
15.
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients.
Clin Lung Cancer
; 23(3): e243-e246, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34393061
16.
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network.
Eur J Cancer
; 162: 118-127, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965496
17.
Lung cancer survivors and employment: A systematic review.
Lung Cancer
; 131: 31-39, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027695
18.
Incidence of thyroid dysfunctions during treatment with nivolumab for non-small cell lung cancer: Retrospective study of 105 patients.
Presse Med
; 48(4): e199-e207, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005502
19.
Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.
Cancers (Basel)
; 11(12)2019 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766357
20.
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study.
Clin Lung Cancer
; 19(3): e277-e285, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29221762